6447-PR) inhibits TRANCE-induced osteoclast differentiation in the RAW 264.7 mouse monocyte/macrophage cell line in a dose-dependent manner (orange line), as measured by the Tartrate-resistant acid phosphatase activity assay. Under these conditions, TRANCE-induced osteoclast differentiation inhibited by Recombinant Human PRELP (5 µg/ml) is neutralized (green line) by increasing concentrations of Mouse Anti-Human PRELP Monoclonal Antibody (Catalog # MAB64471) in the presence of 5 ng/mL Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog #
462-TEC) and 20 ng/mL Recombinant Mouse M-CSF (Catalog #
416-ML). The ND
50 is typically 0.25-1.25 µg/mL." class="big_lightbox">

6447-PR) inhibits TRANCE-induced osteoclast differentiation in the RAW 264.7 mouse monocyte/macrophage cell line in a dose-dependent manner (orange line), as measured by the Tartrate-resistant acid phosphatase activity assay. Under these conditions, TRANCE-induced osteoclast differentiation inhibited by Recombinant Human PRELP (5 µg/ml) is neutralized (green line) by increasing concentrations of Mouse Anti-Human PRELP Monoclonal Antibody (Catalog # MAB64471) in the presence of 5 ng/mL Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog #
462-TEC) and 20 ng/mL Recombinant Mouse M-CSF (Catalog #
416-ML). The ND
50 is typically 0.25-1.25 µg/mL." alt="Recombinant Human PRELP (Catalog #
6447-PR) inhibits TRANCE-induced osteoclast differentiation in the RAW 264.7 mouse monocyte/macrophage cell line in a dose-dependent manner (orange line), as measured by the Tartrate-resistant acid phosphatase activity assay. Under these conditions, TRANCE-induced osteoclast differentiation inhibited by Recombinant Human PRELP (5 µg/ml) is neutralized (green line) by increasing concentrations of Mouse Anti-Human PRELP Monoclonal Antibody (Catalog # MAB64471) in the presence of 5 ng/mL Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog #
462-TEC) and 20 ng/mL Recombinant Mouse M-CSF (Catalog #
416-ML). The ND
50 is typically 0.25-1.25 µg/mL." class="big_thumb" />